In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer licenses generics portfolio from Aurobindo Pharma

Executive Summary

Indian generics company Aurobindo Pharma has licensed Pfizer rights to market and commercialize 39 oral generics in the US, with 20 of those to be sold in Europe (11 in France). In addition, Pfizer gets rights to sell 12 sterile injectable antibiotics (penicillin and cephalosporin) in the US and Europe.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies